Search Site


Answer Centre - Telephone Answering in your Company Name by an Answer Centre PA


Entelos teams up with GlaxoSmithKline over new research

04 February 2009

Entelos, the biotech company that works on what is known as predictive disease simulation for pharmaceutical, health-care and consumer products applications, has signed a research deal with drugs giant GlaxoSmithKline.

The agreement between the company will see them conduct in silico research using the Entelos Hematopoeisis PhysioLab platform.

The Entelos Hematopoeisis PhysioLab platform is a powerful computer model that can simulate the complex biology of anemic patients and large “virtual patient populations” to predict responses to drugs. It has already been used successfully with other pharmaceutical partners to assess the safety and efficacy of biologics, find the best doses for specific patient types, and optimise complicated, adaptive clinical trial designs to better position products in the highly competitive market for anti-anemia drugs.






Headlines

31 August 2010

30 August 2010

27 August 2010

20 August 2010

18 August 2010

13 August 2010

09 August 2010

06 August 2010

30 July 2010

29 July 2010

28 July 2010

27 July 2010

26 July 2010

23 July 2010

23 July 2010

22 July 2010

21 July 2010

19 July 2010

16 July 2010

12 July 2010

09 July 2010

08 July 2010

07 July 2010

06 July 2010

05 July 2010

02 July 2010

06 May 2010

13 April 2010

24 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

19 March 2010

19 March 2010

» See all News




© SmallCapNews   |   Contact Us   |   Terms of Use   |   RSS Feeds Site by LunarSafari